Fiche centre
Liuzhou People's Hospital
Liuzhou — China
Essais liés5clinical trials
VilleLiuzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06531824
Essais cliniques associés
5| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Selatogrel | Maladie coronarienne | Phase 3 | NCT04957719 | SOS-AMI — Selatogrel Outcome Study in Suspected Acute Myocardial Infarction | ENROLLING_BY_INVITATION |
| Qishen Yiqi Dripping Pills 2 bags | Insuffisance cardiaque | Phase 3 | NCT07687186 | Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre | RECRUITING |
| Nivolumab | Cancer | Phase 3 | NCT06561386 | RELATIVITY1093 — A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1% | RECRUITING |
| BI 690517 | Maladie rénale chronique | Phase 3 | NCT06531824 | EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) | ACTIVE_NOT_RECRUITING |
| Prophylactic Impacted Tooth Extraction | Cancer | Non applicable | NCT07764887 | Impacted Tooth Management and Osteoradionecrosis Risk in NPC | NOT_YET_RECRUITING |